Elemis has launched a range of Biotec products to complement the treatments
Elemis has revealed it is thriving financially, despite the UK’s vote to leave the EU on 23 June.
Speaking at a trade industry update, Noella Gabriel, Co-Founder and Creator of Elemis Therapies, confirmed that the business would close the year on double-digit growth.
Elemis closed 2015 at $75m, and for 2016 Cosmetics Business can reveal it is predicted to close on $82m, with over 10% growth.
She said: “We all wobbled after Brexit. We were romping along and having a phenomenal year, and then [in] June we wobbled
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.
Subscribe now Already a subscriber? Sign in here.
